A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
Clinical trial NCT06190639 · RECRUITING
Trial details
- NCT number
- NCT06190639
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2025-12-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.